Why We Bought Johnson & Johnson
November 05, 2015 at 09:32 AM EST
JNJ's Q3 results continued to be impacted by foreign exchange rate headwinds and hepatitis C competition, but underlying growth remains solid. Learn why we own this dividend aristocrat.
